Problem 1: What are the ethical issues that are relevant today with regard to pharmaceutical coverage, pricing, and access? Is there a role for corporate social responsibility on the part of life sciences executives?
Problem 2: What is the role of the federal government in ensuring that the citizens of the US have access to affordable pharmaceutical and biotechnology products?